2BBBullish & Bearish
Globus Medical, Inc. Class A Common Stock (GMED) trades on NYSE. It operates in the Health Care sector, Medical Devices industry. Its current 2BB score is 62 out of 100.
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
Globus Medical, Inc. Class A Common Stock’s current 2BB score is 62 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 62 | High |
| Momentum | 48 | Stable |
| Financial strength | 92 | Very Strong |
| Quality | 100 | Very Strong |
| Risk | 32 | Low |
| CEO | Keith Pfeil |
| Founded | 2003 |
| Employees | 6K |
| P/E ratio | 21.11 |
| 52-week range | $54.15 – $101.40 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-22 | — | 1.3675 | — | $875.06M |
| 2026-11-04 | — | 1.2196 | — | $808.10M |
| 2026-08-06 | — | 1.1213 | — | $798.50M |
| 2026-05-07 | 1.12 | 0.9381 | $759.85M | $751.74M |